AI clinical trial simulation company QuantHealth raised $45 million in Series B funding. Qumra Capital led the round, with participation from Pitango HealthTech, Sanofi Ventures, Artofin Venture ...

Artificial intelligence (AI) has been revolutionizing much of early drug discovery, yet human clinical trials remain a bottleneck. Now some applications of the new technologies are bringing ...

The company’s solutions allow life sciences enterprises to move away from designing clinical trials based on subjective assumptions toward launching trials that have been tested, optimized, and ...

A person wears virtual reality goggles to view and manipulate images in the Living Heart Project. (Photo: Courtesy of Dassault Systèmes and the Living Heart Project) Clinical trials can be very ...

QuantHealth's AI-powered clinical simulator predicts how an individual in a clinical trial will respond to treatment. The aim is to assist pharmaceutical companies in improving their clinical trial ...

QuantHealth, a global leader in AI-driven clinical trial simulation, today announced a $45 million Series B. The round was led by Qumra Capital, with support from additional investors, including ...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and ...

Before a drug or medical device is approved for use in humans, it must undergo a clinical trial. Clinical trials ultimately aim to answer two simple questions: is the drug or device safe? And does it ...

The practicum is a critical piece of experiential learning for students entering health-care fields as they learn to navigate interacting with patients and providing professional care. At Touro ...

Before a drug or medical device is approved for use in humans, it must undergo a clinical trial. Clinical trials ultimately aim to answer two simple questions: is the drug or device safe? And does it ...